Advertisement

Index by author

August 01, 1994; Volume 46,Issue 2

A

  1. Ahmad, S

    1. Ligand binding characterization and molecular analysis of distinct epidermal growth factor-urogastrone receptors in cultured smooth muscle and epithelial cells from guinea pig intestine.
      S G Yang, S Ahmad, N C Wong and M D Hollenberg
      Molecular Pharmacology August 1994, 46 (2) 256-265;

  2. Asghari, V

    1. Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes.
      V Asghari, O Schoots, S van Kats, K Ohara, V Jovanovic, H C Guan, J R Bunzow, A Petronis and H H Van Tol
      Molecular Pharmacology August 1994, 46 (2) 364-373;

B

  1. Badman, G T

    1. Characterization of a new, highly specific, beta 3-adrenergic receptor radioligand, [3H]SB 206606.
      P Muzzin, O Boss, N Mathis, J P Revelli, J P Giacobino, K Willcocks, G T Badman, B C Cantello, R M Hindley and M A Cawthorne
      Molecular Pharmacology August 1994, 46 (2) 357-363;

  2. Baez, M

    1. Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor.
      J D Kursar, D L Nelson, D B Wainscott and M Baez
      Molecular Pharmacology August 1994, 46 (2) 227-234;

  3. Bailey, T J

    1. Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.
      J W Regan, T J Bailey, D J Pepperl, K L Pierce, A M Bogardus, J E Donello, C E Fairbairn, K M Kedzie, D F Woodward and D W Gil
      Molecular Pharmacology August 1994, 46 (2) 213-220;

  4. Bailly, C

    1. Sequence-selective binding to DNA of cis- and trans- butamidine analogues of the anti-Pneumocystis carinii pneumonia drug pentamidine.
      C Bailly, I O Donkor, D Gentle, M Thornalley and M J Waring
      Molecular Pharmacology August 1994, 46 (2) 313-322;

  5. Barr, A J

    1. Protein kinase C mediates delayed inhibitory feedback regulation of human neurokinin type 1 receptor activation of phospholipase C in UC11 astrocytoma cells.
      A J Barr and S P Watson
      Molecular Pharmacology August 1994, 46 (2) 266-273;

  6. Battey, J F

    1. Gastrin-releasing peptide receptor-induced internalization, down-regulation, desensitization, and growth: possible role for cyclic AMP.
      R V Benya, Z Fathi, T Kusui, T Pradhan, J F Battey and R T Jensen
      Molecular Pharmacology August 1994, 46 (2) 235-245;

  7. Benya, R V

    1. Gastrin-releasing peptide receptor-induced internalization, down-regulation, desensitization, and growth: possible role for cyclic AMP.
      R V Benya, Z Fathi, T Kusui, T Pradhan, J F Battey and R T Jensen
      Molecular Pharmacology August 1994, 46 (2) 235-245;

  8. Berkowitz, D E

    1. Expression of alpha 1-adrenergic receptor subtype mRNA in rat tissues and human SK-N-MC neuronal cells: implications for alpha 1-adrenergic receptor subtype classification.
      D T Price, R S Chari, D E Berkowitz, W C Meyers and D A Schwinn
      Molecular Pharmacology August 1994, 46 (2) 221-226;

  9. Blumberg, P M

    1. Binding of [26-3H]bryostatin 1 and analogs to calcium-dependent and calcium-independent protein kinase C isozymes.
      M G Kazanietz, N E Lewin, F Gao, G R Pettit and P M Blumberg
      Molecular Pharmacology August 1994, 46 (2) 374-379;

  10. Bogardus, A M

    1. Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.
      J W Regan, T J Bailey, D J Pepperl, K L Pierce, A M Bogardus, J E Donello, C E Fairbairn, K M Kedzie, D F Woodward and D W Gil
      Molecular Pharmacology August 1994, 46 (2) 213-220;

  11. Boss, O

    1. Characterization of a new, highly specific, beta 3-adrenergic receptor radioligand, [3H]SB 206606.
      P Muzzin, O Boss, N Mathis, J P Revelli, J P Giacobino, K Willcocks, G T Badman, B C Cantello, R M Hindley and M A Cawthorne
      Molecular Pharmacology August 1994, 46 (2) 357-363;

  12. Boulanger, C M

    1. Simultaneous activation of adenylyl cyclase and protein kinase C induces production of nitric oxide by vascular smooth muscle cells.
      T Scott-Burden, E Elizondo, T Ge, C M Boulanger and P M Vanhoutte
      Molecular Pharmacology August 1994, 46 (2) 274-282;

  13. Bruggemann, E P

    1. Localization of the forskolin labeling sites to both halves of P-glycoprotein: similarity of the sites labeled by forskolin and prazosin.
      D I Morris, L M Greenberger, E P Bruggemann, C Cardarelli, M M Gottesman, I Pastan and K B Seamon
      Molecular Pharmacology August 1994, 46 (2) 329-337;

  14. Bunzow, J R

    1. Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes.
      V Asghari, O Schoots, S van Kats, K Ohara, V Jovanovic, H C Guan, J R Bunzow, A Petronis and H H Van Tol
      Molecular Pharmacology August 1994, 46 (2) 364-373;

  15. Burnett, V L

    1. Site-directed mutagenesis of putative substrate recognition sites in cytochrome P450 2B11: importance of amino acid residues 114, 290, and 363 for substrate specificity.
      J A Hasler, G R Harlow, G D Szklarz, G H John, K M Kedzie, V L Burnett, Y A He, L S Kaminsky and J R Halpert
      Molecular Pharmacology August 1994, 46 (2) 338-345;

  16. Butt, E

    1. Human cyclic GMP-dependent protein kinase I beta overexpression increases phosphorylation of an endogenous focal contact-associated vasodilator-stimulated phosphoprotein without altering the thrombin-evoked calcium response.
      M Meinecke, J Geiger, E Butt, M Sandberg, T Jahnsen, T Chakraborty, U Walter, T Jarchau and S M Lohmann
      Molecular Pharmacology August 1994, 46 (2) 283-290;

C

  1. Cantello, B C

    1. Characterization of a new, highly specific, beta 3-adrenergic receptor radioligand, [3H]SB 206606.
      P Muzzin, O Boss, N Mathis, J P Revelli, J P Giacobino, K Willcocks, G T Badman, B C Cantello, R M Hindley and M A Cawthorne
      Molecular Pharmacology August 1994, 46 (2) 357-363;

  2. Cardarelli, C

    1. Localization of the forskolin labeling sites to both halves of P-glycoprotein: similarity of the sites labeled by forskolin and prazosin.
      D I Morris, L M Greenberger, E P Bruggemann, C Cardarelli, M M Gottesman, I Pastan and K B Seamon
      Molecular Pharmacology August 1994, 46 (2) 329-337;

  3. Caron, M G

    1. High affinity agonist binding to the dopamine D3 receptor: chimeric receptors delineate a role for intracellular domains.
      S W Robinson, K R Jarvie and M G Caron
      Molecular Pharmacology August 1994, 46 (2) 352-356;

  4. Casabianca-Pignède, M R

    1. Expression of topoisomerases II alpha and beta in Chinese hamster lung cells resistant to topoisomerase II inhibitors.
      T Khélifa, M R Casabianca-Pignède, B René and A Jacquemin-Sablon
      Molecular Pharmacology August 1994, 46 (2) 323-328;

  5. Cawthorne, M A

    1. Characterization of a new, highly specific, beta 3-adrenergic receptor radioligand, [3H]SB 206606.
      P Muzzin, O Boss, N Mathis, J P Revelli, J P Giacobino, K Willcocks, G T Badman, B C Cantello, R M Hindley and M A Cawthorne
      Molecular Pharmacology August 1994, 46 (2) 357-363;

  6. Chakraborty, T

    1. Human cyclic GMP-dependent protein kinase I beta overexpression increases phosphorylation of an endogenous focal contact-associated vasodilator-stimulated phosphoprotein without altering the thrombin-evoked calcium response.
      M Meinecke, J Geiger, E Butt, M Sandberg, T Jahnsen, T Chakraborty, U Walter, T Jarchau and S M Lohmann
      Molecular Pharmacology August 1994, 46 (2) 283-290;

  7. Chamulitrat, W

    1. Nitric oxide production during endotoxic shock in carbon tetrachloride-treated rats.
      W Chamulitrat, S J Jordan and R P Mason
      Molecular Pharmacology August 1994, 46 (2) 391-397;

  8. Chari, R S

    1. Expression of alpha 1-adrenergic receptor subtype mRNA in rat tissues and human SK-N-MC neuronal cells: implications for alpha 1-adrenergic receptor subtype classification.
      D T Price, R S Chari, D E Berkowitz, W C Meyers and D A Schwinn
      Molecular Pharmacology August 1994, 46 (2) 221-226;

D

  1. Donello, J E

    1. Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.
      J W Regan, T J Bailey, D J Pepperl, K L Pierce, A M Bogardus, J E Donello, C E Fairbairn, K M Kedzie, D F Woodward and D W Gil
      Molecular Pharmacology August 1994, 46 (2) 213-220;

  2. Donkor, I O

    1. Sequence-selective binding to DNA of cis- and trans- butamidine analogues of the anti-Pneumocystis carinii pneumonia drug pentamidine.
      C Bailly, I O Donkor, D Gentle, M Thornalley and M J Waring
      Molecular Pharmacology August 1994, 46 (2) 313-322;

E

  1. Elizondo, E

    1. Simultaneous activation of adenylyl cyclase and protein kinase C induces production of nitric oxide by vascular smooth muscle cells.
      T Scott-Burden, E Elizondo, T Ge, C M Boulanger and P M Vanhoutte
      Molecular Pharmacology August 1994, 46 (2) 274-282;

  2. Elrod, R D

    1. Cloning and characterization of an abundant subtype of the human calcitonin receptor.
      R E Kuestner, R D Elrod, F J Grant, F S Hagen, J L Kuijper, S L Matthewes, P J O'Hara, P O Sheppard, S D Stroop and D L Thompson
      Molecular Pharmacology August 1994, 46 (2) 246-255;

F

  1. Fairbairn, C E

    1. Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.
      J W Regan, T J Bailey, D J Pepperl, K L Pierce, A M Bogardus, J E Donello, C E Fairbairn, K M Kedzie, D F Woodward and D W Gil
      Molecular Pharmacology August 1994, 46 (2) 213-220;

  2. Fathi, Z

    1. Gastrin-releasing peptide receptor-induced internalization, down-regulation, desensitization, and growth: possible role for cyclic AMP.
      R V Benya, Z Fathi, T Kusui, T Pradhan, J F Battey and R T Jensen
      Molecular Pharmacology August 1994, 46 (2) 235-245;

  3. Ferguson, J E

    1. Attenuation of agonist-induced desensitization of the rat substance P receptor by microinjection of inositol pentakis-and hexakisphosphates in Xenopus laevis oocytes.
      N Sasakawa, J E Ferguson, M Sharif and M R Hanley
      Molecular Pharmacology August 1994, 46 (2) 380-385;

G

  1. Gao, F

    1. Binding of [26-3H]bryostatin 1 and analogs to calcium-dependent and calcium-independent protein kinase C isozymes.
      M G Kazanietz, N E Lewin, F Gao, G R Pettit and P M Blumberg
      Molecular Pharmacology August 1994, 46 (2) 374-379;

  2. Ge, T

    1. Simultaneous activation of adenylyl cyclase and protein kinase C induces production of nitric oxide by vascular smooth muscle cells.
      T Scott-Burden, E Elizondo, T Ge, C M Boulanger and P M Vanhoutte
      Molecular Pharmacology August 1994, 46 (2) 274-282;

  3. Geiger, J

    1. Human cyclic GMP-dependent protein kinase I beta overexpression increases phosphorylation of an endogenous focal contact-associated vasodilator-stimulated phosphoprotein without altering the thrombin-evoked calcium response.
      M Meinecke, J Geiger, E Butt, M Sandberg, T Jahnsen, T Chakraborty, U Walter, T Jarchau and S M Lohmann
      Molecular Pharmacology August 1994, 46 (2) 283-290;

  4. Gentle, D

    1. Sequence-selective binding to DNA of cis- and trans- butamidine analogues of the anti-Pneumocystis carinii pneumonia drug pentamidine.
      C Bailly, I O Donkor, D Gentle, M Thornalley and M J Waring
      Molecular Pharmacology August 1994, 46 (2) 313-322;

  5. Giacobino, J P

    1. Characterization of a new, highly specific, beta 3-adrenergic receptor radioligand, [3H]SB 206606.
      P Muzzin, O Boss, N Mathis, J P Revelli, J P Giacobino, K Willcocks, G T Badman, B C Cantello, R M Hindley and M A Cawthorne
      Molecular Pharmacology August 1994, 46 (2) 357-363;

  6. Gil, D W

    1. Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.
      J W Regan, T J Bailey, D J Pepperl, K L Pierce, A M Bogardus, J E Donello, C E Fairbairn, K M Kedzie, D F Woodward and D W Gil
      Molecular Pharmacology August 1994, 46 (2) 213-220;

  7. Gottesman, M M

    1. Localization of the forskolin labeling sites to both halves of P-glycoprotein: similarity of the sites labeled by forskolin and prazosin.
      D I Morris, L M Greenberger, E P Bruggemann, C Cardarelli, M M Gottesman, I Pastan and K B Seamon
      Molecular Pharmacology August 1994, 46 (2) 329-337;

  8. Grant, F J

    1. Cloning and characterization of an abundant subtype of the human calcitonin receptor.
      R E Kuestner, R D Elrod, F J Grant, F S Hagen, J L Kuijper, S L Matthewes, P J O'Hara, P O Sheppard, S D Stroop and D L Thompson
      Molecular Pharmacology August 1994, 46 (2) 246-255;

  9. Greenberger, L M

    1. Localization of the forskolin labeling sites to both halves of P-glycoprotein: similarity of the sites labeled by forskolin and prazosin.
      D I Morris, L M Greenberger, E P Bruggemann, C Cardarelli, M M Gottesman, I Pastan and K B Seamon
      Molecular Pharmacology August 1994, 46 (2) 329-337;

  10. Gruntmeir, J J

    1. Peroxidase activity in murine and human hematopoietic progenitor cells: potential relevance to benzene-induced toxicity.
      D G Schattenberg, W S Stillman, J J Gruntmeir, K M Helm, R D Irons and D Ross
      Molecular Pharmacology August 1994, 46 (2) 346-351;

  11. Guan, H C

    1. Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes.
      V Asghari, O Schoots, S van Kats, K Ohara, V Jovanovic, H C Guan, J R Bunzow, A Petronis and H H Van Tol
      Molecular Pharmacology August 1994, 46 (2) 364-373;

H

  1. Hacksell, U

    1. Molecular basis for the binding of 2-aminotetralins to human dopamine D2A and D3 receptors.
      A Malmberg, G Nordvall, A M Johansson, N Mohell and U Hacksell
      Molecular Pharmacology August 1994, 46 (2) 299-312;

  2. Hagen, F S

    1. Cloning and characterization of an abundant subtype of the human calcitonin receptor.
      R E Kuestner, R D Elrod, F J Grant, F S Hagen, J L Kuijper, S L Matthewes, P J O'Hara, P O Sheppard, S D Stroop and D L Thompson
      Molecular Pharmacology August 1994, 46 (2) 246-255;

  3. Halpert, J R

    1. Site-directed mutagenesis of putative substrate recognition sites in cytochrome P450 2B11: importance of amino acid residues 114, 290, and 363 for substrate specificity.
      J A Hasler, G R Harlow, G D Szklarz, G H John, K M Kedzie, V L Burnett, Y A He, L S Kaminsky and J R Halpert
      Molecular Pharmacology August 1994, 46 (2) 338-345;

  4. Hanley, M R

    1. Attenuation of agonist-induced desensitization of the rat substance P receptor by microinjection of inositol pentakis-and hexakisphosphates in Xenopus laevis oocytes.
      N Sasakawa, J E Ferguson, M Sharif and M R Hanley
      Molecular Pharmacology August 1994, 46 (2) 380-385;

  5. Harlow, G R

    1. Site-directed mutagenesis of putative substrate recognition sites in cytochrome P450 2B11: importance of amino acid residues 114, 290, and 363 for substrate specificity.
      J A Hasler, G R Harlow, G D Szklarz, G H John, K M Kedzie, V L Burnett, Y A He, L S Kaminsky and J R Halpert
      Molecular Pharmacology August 1994, 46 (2) 338-345;

  6. Hasler, J A

    1. Site-directed mutagenesis of putative substrate recognition sites in cytochrome P450 2B11: importance of amino acid residues 114, 290, and 363 for substrate specificity.
      J A Hasler, G R Harlow, G D Szklarz, G H John, K M Kedzie, V L Burnett, Y A He, L S Kaminsky and J R Halpert
      Molecular Pharmacology August 1994, 46 (2) 338-345;

  7. He, Y A

    1. Site-directed mutagenesis of putative substrate recognition sites in cytochrome P450 2B11: importance of amino acid residues 114, 290, and 363 for substrate specificity.
      J A Hasler, G R Harlow, G D Szklarz, G H John, K M Kedzie, V L Burnett, Y A He, L S Kaminsky and J R Halpert
      Molecular Pharmacology August 1994, 46 (2) 338-345;

  8. Helm, K M

    1. Peroxidase activity in murine and human hematopoietic progenitor cells: potential relevance to benzene-induced toxicity.
      D G Schattenberg, W S Stillman, J J Gruntmeir, K M Helm, R D Irons and D Ross
      Molecular Pharmacology August 1994, 46 (2) 346-351;

  9. Hindley, R M

    1. Characterization of a new, highly specific, beta 3-adrenergic receptor radioligand, [3H]SB 206606.
      P Muzzin, O Boss, N Mathis, J P Revelli, J P Giacobino, K Willcocks, G T Badman, B C Cantello, R M Hindley and M A Cawthorne
      Molecular Pharmacology August 1994, 46 (2) 357-363;

  10. Hollenberg, M D

    1. Ligand binding characterization and molecular analysis of distinct epidermal growth factor-urogastrone receptors in cultured smooth muscle and epithelial cells from guinea pig intestine.
      S G Yang, S Ahmad, N C Wong and M D Hollenberg
      Molecular Pharmacology August 1994, 46 (2) 256-265;

I

  1. Irons, R D

    1. Peroxidase activity in murine and human hematopoietic progenitor cells: potential relevance to benzene-induced toxicity.
      D G Schattenberg, W S Stillman, J J Gruntmeir, K M Helm, R D Irons and D Ross
      Molecular Pharmacology August 1994, 46 (2) 346-351;

J

  1. Jacquemin-Sablon, A

    1. Expression of topoisomerases II alpha and beta in Chinese hamster lung cells resistant to topoisomerase II inhibitors.
      T Khélifa, M R Casabianca-Pignède, B René and A Jacquemin-Sablon
      Molecular Pharmacology August 1994, 46 (2) 323-328;

  2. Jahnsen, T

    1. Human cyclic GMP-dependent protein kinase I beta overexpression increases phosphorylation of an endogenous focal contact-associated vasodilator-stimulated phosphoprotein without altering the thrombin-evoked calcium response.
      M Meinecke, J Geiger, E Butt, M Sandberg, T Jahnsen, T Chakraborty, U Walter, T Jarchau and S M Lohmann
      Molecular Pharmacology August 1994, 46 (2) 283-290;

  3. Jarchau, T

    1. Human cyclic GMP-dependent protein kinase I beta overexpression increases phosphorylation of an endogenous focal contact-associated vasodilator-stimulated phosphoprotein without altering the thrombin-evoked calcium response.
      M Meinecke, J Geiger, E Butt, M Sandberg, T Jahnsen, T Chakraborty, U Walter, T Jarchau and S M Lohmann
      Molecular Pharmacology August 1994, 46 (2) 283-290;

  4. Jarvie, K R

    1. High affinity agonist binding to the dopamine D3 receptor: chimeric receptors delineate a role for intracellular domains.
      S W Robinson, K R Jarvie and M G Caron
      Molecular Pharmacology August 1994, 46 (2) 352-356;

  5. Jensen, R T

    1. Gastrin-releasing peptide receptor-induced internalization, down-regulation, desensitization, and growth: possible role for cyclic AMP.
      R V Benya, Z Fathi, T Kusui, T Pradhan, J F Battey and R T Jensen
      Molecular Pharmacology August 1994, 46 (2) 235-245;

  6. Johansson, A M

    1. Molecular basis for the binding of 2-aminotetralins to human dopamine D2A and D3 receptors.
      A Malmberg, G Nordvall, A M Johansson, N Mohell and U Hacksell
      Molecular Pharmacology August 1994, 46 (2) 299-312;

  7. John, G H

    1. Site-directed mutagenesis of putative substrate recognition sites in cytochrome P450 2B11: importance of amino acid residues 114, 290, and 363 for substrate specificity.
      J A Hasler, G R Harlow, G D Szklarz, G H John, K M Kedzie, V L Burnett, Y A He, L S Kaminsky and J R Halpert
      Molecular Pharmacology August 1994, 46 (2) 338-345;

  8. Jordan, S J

    1. Nitric oxide production during endotoxic shock in carbon tetrachloride-treated rats.
      W Chamulitrat, S J Jordan and R P Mason
      Molecular Pharmacology August 1994, 46 (2) 391-397;

  9. Jovanovic, V

    1. Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes.
      V Asghari, O Schoots, S van Kats, K Ohara, V Jovanovic, H C Guan, J R Bunzow, A Petronis and H H Van Tol
      Molecular Pharmacology August 1994, 46 (2) 364-373;

K

  1. Kaminsky, L S

    1. Site-directed mutagenesis of putative substrate recognition sites in cytochrome P450 2B11: importance of amino acid residues 114, 290, and 363 for substrate specificity.
      J A Hasler, G R Harlow, G D Szklarz, G H John, K M Kedzie, V L Burnett, Y A He, L S Kaminsky and J R Halpert
      Molecular Pharmacology August 1994, 46 (2) 338-345;

  2. Kazanietz, M G

    1. Binding of [26-3H]bryostatin 1 and analogs to calcium-dependent and calcium-independent protein kinase C isozymes.
      M G Kazanietz, N E Lewin, F Gao, G R Pettit and P M Blumberg
      Molecular Pharmacology August 1994, 46 (2) 374-379;

  3. Kedzie, K M

    1. Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.
      J W Regan, T J Bailey, D J Pepperl, K L Pierce, A M Bogardus, J E Donello, C E Fairbairn, K M Kedzie, D F Woodward and D W Gil
      Molecular Pharmacology August 1994, 46 (2) 213-220;
    2. Site-directed mutagenesis of putative substrate recognition sites in cytochrome P450 2B11: importance of amino acid residues 114, 290, and 363 for substrate specificity.
      J A Hasler, G R Harlow, G D Szklarz, G H John, K M Kedzie, V L Burnett, Y A He, L S Kaminsky and J R Halpert
      Molecular Pharmacology August 1994, 46 (2) 338-345;

  4. Khélifa, T

    1. Expression of topoisomerases II alpha and beta in Chinese hamster lung cells resistant to topoisomerase II inhibitors.
      T Khélifa, M R Casabianca-Pignède, B René and A Jacquemin-Sablon
      Molecular Pharmacology August 1994, 46 (2) 323-328;

  5. Kuestner, R E

    1. Cloning and characterization of an abundant subtype of the human calcitonin receptor.
      R E Kuestner, R D Elrod, F J Grant, F S Hagen, J L Kuijper, S L Matthewes, P J O'Hara, P O Sheppard, S D Stroop and D L Thompson
      Molecular Pharmacology August 1994, 46 (2) 246-255;

  6. Kuijper, J L

    1. Cloning and characterization of an abundant subtype of the human calcitonin receptor.
      R E Kuestner, R D Elrod, F J Grant, F S Hagen, J L Kuijper, S L Matthewes, P J O'Hara, P O Sheppard, S D Stroop and D L Thompson
      Molecular Pharmacology August 1994, 46 (2) 246-255;

  7. Kursar, J D

    1. Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor.
      J D Kursar, D L Nelson, D B Wainscott and M Baez
      Molecular Pharmacology August 1994, 46 (2) 227-234;

  8. Kusui, T

    1. Gastrin-releasing peptide receptor-induced internalization, down-regulation, desensitization, and growth: possible role for cyclic AMP.
      R V Benya, Z Fathi, T Kusui, T Pradhan, J F Battey and R T Jensen
      Molecular Pharmacology August 1994, 46 (2) 235-245;

L

  1. Lewin, N E

    1. Binding of [26-3H]bryostatin 1 and analogs to calcium-dependent and calcium-independent protein kinase C isozymes.
      M G Kazanietz, N E Lewin, F Gao, G R Pettit and P M Blumberg
      Molecular Pharmacology August 1994, 46 (2) 374-379;

  2. Lohmann, S M

    1. Human cyclic GMP-dependent protein kinase I beta overexpression increases phosphorylation of an endogenous focal contact-associated vasodilator-stimulated phosphoprotein without altering the thrombin-evoked calcium response.
      M Meinecke, J Geiger, E Butt, M Sandberg, T Jahnsen, T Chakraborty, U Walter, T Jarchau and S M Lohmann
      Molecular Pharmacology August 1994, 46 (2) 283-290;

  3. Lolait, S J

    1. Characterization of cloned human somatostatin receptor SSTR5.
      A M O'Carroll, K Raynor, S J Lolait and T Reisine
      Molecular Pharmacology August 1994, 46 (2) 291-298;

M

  1. Maksay, G

    1. Thermodynamics of gamma-aminobutyric acid type A receptor binding differentiate agonists from antagonists.
      G Maksay
      Molecular Pharmacology August 1994, 46 (2) 386-390;

  2. Malmberg, A

    1. Molecular basis for the binding of 2-aminotetralins to human dopamine D2A and D3 receptors.
      A Malmberg, G Nordvall, A M Johansson, N Mohell and U Hacksell
      Molecular Pharmacology August 1994, 46 (2) 299-312;

  3. Mason, R P

    1. Nitric oxide production during endotoxic shock in carbon tetrachloride-treated rats.
      W Chamulitrat, S J Jordan and R P Mason
      Molecular Pharmacology August 1994, 46 (2) 391-397;

  4. Mathis, N

    1. Characterization of a new, highly specific, beta 3-adrenergic receptor radioligand, [3H]SB 206606.
      P Muzzin, O Boss, N Mathis, J P Revelli, J P Giacobino, K Willcocks, G T Badman, B C Cantello, R M Hindley and M A Cawthorne
      Molecular Pharmacology August 1994, 46 (2) 357-363;

  5. Matthewes, S L

    1. Cloning and characterization of an abundant subtype of the human calcitonin receptor.
      R E Kuestner, R D Elrod, F J Grant, F S Hagen, J L Kuijper, S L Matthewes, P J O'Hara, P O Sheppard, S D Stroop and D L Thompson
      Molecular Pharmacology August 1994, 46 (2) 246-255;

  6. Meinecke, M

    1. Human cyclic GMP-dependent protein kinase I beta overexpression increases phosphorylation of an endogenous focal contact-associated vasodilator-stimulated phosphoprotein without altering the thrombin-evoked calcium response.
      M Meinecke, J Geiger, E Butt, M Sandberg, T Jahnsen, T Chakraborty, U Walter, T Jarchau and S M Lohmann
      Molecular Pharmacology August 1994, 46 (2) 283-290;

  7. Meyers, W C

    1. Expression of alpha 1-adrenergic receptor subtype mRNA in rat tissues and human SK-N-MC neuronal cells: implications for alpha 1-adrenergic receptor subtype classification.
      D T Price, R S Chari, D E Berkowitz, W C Meyers and D A Schwinn
      Molecular Pharmacology August 1994, 46 (2) 221-226;

  8. Mohell, N

    1. Molecular basis for the binding of 2-aminotetralins to human dopamine D2A and D3 receptors.
      A Malmberg, G Nordvall, A M Johansson, N Mohell and U Hacksell
      Molecular Pharmacology August 1994, 46 (2) 299-312;

  9. Morris, D I

    1. Localization of the forskolin labeling sites to both halves of P-glycoprotein: similarity of the sites labeled by forskolin and prazosin.
      D I Morris, L M Greenberger, E P Bruggemann, C Cardarelli, M M Gottesman, I Pastan and K B Seamon
      Molecular Pharmacology August 1994, 46 (2) 329-337;

  10. Muzzin, P

    1. Characterization of a new, highly specific, beta 3-adrenergic receptor radioligand, [3H]SB 206606.
      P Muzzin, O Boss, N Mathis, J P Revelli, J P Giacobino, K Willcocks, G T Badman, B C Cantello, R M Hindley and M A Cawthorne
      Molecular Pharmacology August 1994, 46 (2) 357-363;

N

  1. Nelson, D L

    1. Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor.
      J D Kursar, D L Nelson, D B Wainscott and M Baez
      Molecular Pharmacology August 1994, 46 (2) 227-234;

  2. Nordvall, G

    1. Molecular basis for the binding of 2-aminotetralins to human dopamine D2A and D3 receptors.
      A Malmberg, G Nordvall, A M Johansson, N Mohell and U Hacksell
      Molecular Pharmacology August 1994, 46 (2) 299-312;

O

  1. O'Carroll, A M

    1. Characterization of cloned human somatostatin receptor SSTR5.
      A M O'Carroll, K Raynor, S J Lolait and T Reisine
      Molecular Pharmacology August 1994, 46 (2) 291-298;

  2. O'Hara, P J

    1. Cloning and characterization of an abundant subtype of the human calcitonin receptor.
      R E Kuestner, R D Elrod, F J Grant, F S Hagen, J L Kuijper, S L Matthewes, P J O'Hara, P O Sheppard, S D Stroop and D L Thompson
      Molecular Pharmacology August 1994, 46 (2) 246-255;

  3. Ohara, K

    1. Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes.
      V Asghari, O Schoots, S van Kats, K Ohara, V Jovanovic, H C Guan, J R Bunzow, A Petronis and H H Van Tol
      Molecular Pharmacology August 1994, 46 (2) 364-373;

P

  1. Pastan, I

    1. Localization of the forskolin labeling sites to both halves of P-glycoprotein: similarity of the sites labeled by forskolin and prazosin.
      D I Morris, L M Greenberger, E P Bruggemann, C Cardarelli, M M Gottesman, I Pastan and K B Seamon
      Molecular Pharmacology August 1994, 46 (2) 329-337;

  2. Pepperl, D J

    1. Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.
      J W Regan, T J Bailey, D J Pepperl, K L Pierce, A M Bogardus, J E Donello, C E Fairbairn, K M Kedzie, D F Woodward and D W Gil
      Molecular Pharmacology August 1994, 46 (2) 213-220;

  3. Petronis, A

    1. Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes.
      V Asghari, O Schoots, S van Kats, K Ohara, V Jovanovic, H C Guan, J R Bunzow, A Petronis and H H Van Tol
      Molecular Pharmacology August 1994, 46 (2) 364-373;

  4. Pettit, G R

    1. Binding of [26-3H]bryostatin 1 and analogs to calcium-dependent and calcium-independent protein kinase C isozymes.
      M G Kazanietz, N E Lewin, F Gao, G R Pettit and P M Blumberg
      Molecular Pharmacology August 1994, 46 (2) 374-379;

  5. Pierce, K L

    1. Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.
      J W Regan, T J Bailey, D J Pepperl, K L Pierce, A M Bogardus, J E Donello, C E Fairbairn, K M Kedzie, D F Woodward and D W Gil
      Molecular Pharmacology August 1994, 46 (2) 213-220;

  6. Pradhan, T

    1. Gastrin-releasing peptide receptor-induced internalization, down-regulation, desensitization, and growth: possible role for cyclic AMP.
      R V Benya, Z Fathi, T Kusui, T Pradhan, J F Battey and R T Jensen
      Molecular Pharmacology August 1994, 46 (2) 235-245;

  7. Price, D T

    1. Expression of alpha 1-adrenergic receptor subtype mRNA in rat tissues and human SK-N-MC neuronal cells: implications for alpha 1-adrenergic receptor subtype classification.
      D T Price, R S Chari, D E Berkowitz, W C Meyers and D A Schwinn
      Molecular Pharmacology August 1994, 46 (2) 221-226;

R

  1. Raynor, K

    1. Characterization of cloned human somatostatin receptor SSTR5.
      A M O'Carroll, K Raynor, S J Lolait and T Reisine
      Molecular Pharmacology August 1994, 46 (2) 291-298;

  2. Regan, J W

    1. Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.
      J W Regan, T J Bailey, D J Pepperl, K L Pierce, A M Bogardus, J E Donello, C E Fairbairn, K M Kedzie, D F Woodward and D W Gil
      Molecular Pharmacology August 1994, 46 (2) 213-220;

  3. Reisine, T

    1. Characterization of cloned human somatostatin receptor SSTR5.
      A M O'Carroll, K Raynor, S J Lolait and T Reisine
      Molecular Pharmacology August 1994, 46 (2) 291-298;

  4. René, B

    1. Expression of topoisomerases II alpha and beta in Chinese hamster lung cells resistant to topoisomerase II inhibitors.
      T Khélifa, M R Casabianca-Pignède, B René and A Jacquemin-Sablon
      Molecular Pharmacology August 1994, 46 (2) 323-328;

  5. Revelli, J P

    1. Characterization of a new, highly specific, beta 3-adrenergic receptor radioligand, [3H]SB 206606.
      P Muzzin, O Boss, N Mathis, J P Revelli, J P Giacobino, K Willcocks, G T Badman, B C Cantello, R M Hindley and M A Cawthorne
      Molecular Pharmacology August 1994, 46 (2) 357-363;

  6. Robinson, S W

    1. High affinity agonist binding to the dopamine D3 receptor: chimeric receptors delineate a role for intracellular domains.
      S W Robinson, K R Jarvie and M G Caron
      Molecular Pharmacology August 1994, 46 (2) 352-356;

  7. Ross, D

    1. Peroxidase activity in murine and human hematopoietic progenitor cells: potential relevance to benzene-induced toxicity.
      D G Schattenberg, W S Stillman, J J Gruntmeir, K M Helm, R D Irons and D Ross
      Molecular Pharmacology August 1994, 46 (2) 346-351;

S

  1. Sandberg, M

    1. Human cyclic GMP-dependent protein kinase I beta overexpression increases phosphorylation of an endogenous focal contact-associated vasodilator-stimulated phosphoprotein without altering the thrombin-evoked calcium response.
      M Meinecke, J Geiger, E Butt, M Sandberg, T Jahnsen, T Chakraborty, U Walter, T Jarchau and S M Lohmann
      Molecular Pharmacology August 1994, 46 (2) 283-290;

  2. Sasakawa, N

    1. Attenuation of agonist-induced desensitization of the rat substance P receptor by microinjection of inositol pentakis-and hexakisphosphates in Xenopus laevis oocytes.
      N Sasakawa, J E Ferguson, M Sharif and M R Hanley
      Molecular Pharmacology August 1994, 46 (2) 380-385;

  3. Schattenberg, D G

    1. Peroxidase activity in murine and human hematopoietic progenitor cells: potential relevance to benzene-induced toxicity.
      D G Schattenberg, W S Stillman, J J Gruntmeir, K M Helm, R D Irons and D Ross
      Molecular Pharmacology August 1994, 46 (2) 346-351;

  4. Schoots, O

    1. Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes.
      V Asghari, O Schoots, S van Kats, K Ohara, V Jovanovic, H C Guan, J R Bunzow, A Petronis and H H Van Tol
      Molecular Pharmacology August 1994, 46 (2) 364-373;

  5. Schwinn, D A

    1. Expression of alpha 1-adrenergic receptor subtype mRNA in rat tissues and human SK-N-MC neuronal cells: implications for alpha 1-adrenergic receptor subtype classification.
      D T Price, R S Chari, D E Berkowitz, W C Meyers and D A Schwinn
      Molecular Pharmacology August 1994, 46 (2) 221-226;

  6. Scott-Burden, T

    1. Simultaneous activation of adenylyl cyclase and protein kinase C induces production of nitric oxide by vascular smooth muscle cells.
      T Scott-Burden, E Elizondo, T Ge, C M Boulanger and P M Vanhoutte
      Molecular Pharmacology August 1994, 46 (2) 274-282;

  7. Seamon, K B

    1. Localization of the forskolin labeling sites to both halves of P-glycoprotein: similarity of the sites labeled by forskolin and prazosin.
      D I Morris, L M Greenberger, E P Bruggemann, C Cardarelli, M M Gottesman, I Pastan and K B Seamon
      Molecular Pharmacology August 1994, 46 (2) 329-337;

  8. Sharif, M

    1. Attenuation of agonist-induced desensitization of the rat substance P receptor by microinjection of inositol pentakis-and hexakisphosphates in Xenopus laevis oocytes.
      N Sasakawa, J E Ferguson, M Sharif and M R Hanley
      Molecular Pharmacology August 1994, 46 (2) 380-385;

  9. Sheppard, P O

    1. Cloning and characterization of an abundant subtype of the human calcitonin receptor.
      R E Kuestner, R D Elrod, F J Grant, F S Hagen, J L Kuijper, S L Matthewes, P J O'Hara, P O Sheppard, S D Stroop and D L Thompson
      Molecular Pharmacology August 1994, 46 (2) 246-255;

  10. Stillman, W S

    1. Peroxidase activity in murine and human hematopoietic progenitor cells: potential relevance to benzene-induced toxicity.
      D G Schattenberg, W S Stillman, J J Gruntmeir, K M Helm, R D Irons and D Ross
      Molecular Pharmacology August 1994, 46 (2) 346-351;

  11. Stroop, S D

    1. Cloning and characterization of an abundant subtype of the human calcitonin receptor.
      R E Kuestner, R D Elrod, F J Grant, F S Hagen, J L Kuijper, S L Matthewes, P J O'Hara, P O Sheppard, S D Stroop and D L Thompson
      Molecular Pharmacology August 1994, 46 (2) 246-255;

  12. Szklarz, G D

    1. Site-directed mutagenesis of putative substrate recognition sites in cytochrome P450 2B11: importance of amino acid residues 114, 290, and 363 for substrate specificity.
      J A Hasler, G R Harlow, G D Szklarz, G H John, K M Kedzie, V L Burnett, Y A He, L S Kaminsky and J R Halpert
      Molecular Pharmacology August 1994, 46 (2) 338-345;

T

  1. Thompson, D L

    1. Cloning and characterization of an abundant subtype of the human calcitonin receptor.
      R E Kuestner, R D Elrod, F J Grant, F S Hagen, J L Kuijper, S L Matthewes, P J O'Hara, P O Sheppard, S D Stroop and D L Thompson
      Molecular Pharmacology August 1994, 46 (2) 246-255;

  2. Thornalley, M

    1. Sequence-selective binding to DNA of cis- and trans- butamidine analogues of the anti-Pneumocystis carinii pneumonia drug pentamidine.
      C Bailly, I O Donkor, D Gentle, M Thornalley and M J Waring
      Molecular Pharmacology August 1994, 46 (2) 313-322;

V

  1. Vanhoutte, P M

    1. Simultaneous activation of adenylyl cyclase and protein kinase C induces production of nitric oxide by vascular smooth muscle cells.
      T Scott-Burden, E Elizondo, T Ge, C M Boulanger and P M Vanhoutte
      Molecular Pharmacology August 1994, 46 (2) 274-282;

  2. van Kats, S

    1. Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes.
      V Asghari, O Schoots, S van Kats, K Ohara, V Jovanovic, H C Guan, J R Bunzow, A Petronis and H H Van Tol
      Molecular Pharmacology August 1994, 46 (2) 364-373;

  3. Van Tol, H H

    1. Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes.
      V Asghari, O Schoots, S van Kats, K Ohara, V Jovanovic, H C Guan, J R Bunzow, A Petronis and H H Van Tol
      Molecular Pharmacology August 1994, 46 (2) 364-373;

W

  1. Wainscott, D B

    1. Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor.
      J D Kursar, D L Nelson, D B Wainscott and M Baez
      Molecular Pharmacology August 1994, 46 (2) 227-234;

  2. Walter, U

    1. Human cyclic GMP-dependent protein kinase I beta overexpression increases phosphorylation of an endogenous focal contact-associated vasodilator-stimulated phosphoprotein without altering the thrombin-evoked calcium response.
      M Meinecke, J Geiger, E Butt, M Sandberg, T Jahnsen, T Chakraborty, U Walter, T Jarchau and S M Lohmann
      Molecular Pharmacology August 1994, 46 (2) 283-290;

  3. Waring, M J

    1. Sequence-selective binding to DNA of cis- and trans- butamidine analogues of the anti-Pneumocystis carinii pneumonia drug pentamidine.
      C Bailly, I O Donkor, D Gentle, M Thornalley and M J Waring
      Molecular Pharmacology August 1994, 46 (2) 313-322;

  4. Watson, S P

    1. Protein kinase C mediates delayed inhibitory feedback regulation of human neurokinin type 1 receptor activation of phospholipase C in UC11 astrocytoma cells.
      A J Barr and S P Watson
      Molecular Pharmacology August 1994, 46 (2) 266-273;

  5. Willcocks, K

    1. Characterization of a new, highly specific, beta 3-adrenergic receptor radioligand, [3H]SB 206606.
      P Muzzin, O Boss, N Mathis, J P Revelli, J P Giacobino, K Willcocks, G T Badman, B C Cantello, R M Hindley and M A Cawthorne
      Molecular Pharmacology August 1994, 46 (2) 357-363;

  6. Wong, N C

    1. Ligand binding characterization and molecular analysis of distinct epidermal growth factor-urogastrone receptors in cultured smooth muscle and epithelial cells from guinea pig intestine.
      S G Yang, S Ahmad, N C Wong and M D Hollenberg
      Molecular Pharmacology August 1994, 46 (2) 256-265;

  7. Woodward, D F

    1. Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.
      J W Regan, T J Bailey, D J Pepperl, K L Pierce, A M Bogardus, J E Donello, C E Fairbairn, K M Kedzie, D F Woodward and D W Gil
      Molecular Pharmacology August 1994, 46 (2) 213-220;

Y

  1. Yang, S G

    1. Ligand binding characterization and molecular analysis of distinct epidermal growth factor-urogastrone receptors in cultured smooth muscle and epithelial cells from guinea pig intestine.
      S G Yang, S Ahmad, N C Wong and M D Hollenberg
      Molecular Pharmacology August 1994, 46 (2) 256-265;
Back to top

In this issue

Advertisement